Argus Downgrades Tesla (TSLA) to Hold

Get Alerts TSLA Hot Sheet
Rating Summary:
28 Buy, 18 Hold, 11 Sell
Rating Trend:

Today's Overall Ratings:
Up: 4 | Down: 13 | New: 10
Join SI Premium – FREE
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
Argus analyst Bill Selesky downgraded Tesla (NASDAQ: TSLA) from Buy to Hold.
The analyst comments "We are lowering our rating on Tesla Inc. (NGS: TSLA) to HOLD from BUY as we expect the coronavirus pandemic to have a negative impact on vehicle deliveries. Prior to the outbreak, we had expected fairly robust deliveries from Tesla in 2020, as consumers continued to flock to the Model S, Model X, and more recently, the Model 3 - which accounted for more than 80% of 4Q19 production. In addition, despite past production delays, parts shortages, labor cost overruns, and other difficulties, we had expected Tesla to benefit from its dominant position in the electric vehicle industry and to improve performance in 2020 and subsequent years. We still think that Tesla has strong long-term prospects. However, in the near term, we believe that consumers will focus on basic concerns (food, safety, employment, etc.) and expect consumer confidence and spending to take a major hit as consumers defer large discretionary purchases. Our 2020 delivery forecast for Tesla is now 409,000 vehicles, down 19% from our original forecast."
For an analyst ratings summary and ratings history on Tesla click here. For more ratings news on Tesla click here.
Shares of Tesla closed at $465.20 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla (TSLA) Delivered 254,695 EV Units in Q2, Below Consensus
- BP Plc. (BP:LN) (BP) PT Raised to GBP4.20 at Jefferies
- Equinor (EQNR:NO) (EQNR) PT Raised to NOK350 at Jefferies
Create E-mail Alert Related Categories
Analyst Comments, Downgrades, Hot Comments, Hot DowngradesRelated Entities
Argus, Tesla, Model 3Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!